Chief Scientific Officer for Persica Pharmaceuticals Limited
Lloyd is currently Chief Scientific Officer for Persica Pharmaceuticals Limited, a Director of Chemical Biology Ventures Ltd, which provides life & chemical sciences consultancy services and is a Non-Executive Director at Curza. Previously Lloyd served as an R&D executive for Biota, Prolysis, and British Biotech Pharmaceuticals and Chaired the Novo Repair Impact Fund Scientific Selection Board. He also serves on advisory boards including the WHO Antibiotic Advisory Panel and as a CARB-X Funding Panel member. Lloyd earned his PhD in Molecular Genetics from the University of Glasgow and a First Class B.Sc in Biological Sciences from the University of East Anglia. He is an elected fellow of the Royal Society of Chemistry.
